MDXH
Price
$1.73
Change
+$0.01 (+0.58%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
70.68M
19 days until earnings call
MYO
Price
$4.88
Change
+$0.23 (+4.95%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
93.15M
12 days until earnings call
Ad is loading...

MDXH vs MYO

Header iconMDXH vs MYO Comparison
Open Charts MDXH vs MYOBanner chart's image
MDxHealth SA
Price$1.73
Change+$0.01 (+0.58%)
Volume$909
Capitalization70.68M
Myomo
Price$4.88
Change+$0.23 (+4.95%)
Volume$928
Capitalization93.15M
MDXH vs MYO Comparison Chart
Loading...
MDXH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MYO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MDXH vs. MYO commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDXH is a Buy and MYO is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (MDXH: $1.73 vs. MYO: $4.88)
Brand notoriety: MDXH and MYO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: MDXH: 79% vs. MYO: 49%
Market capitalization -- MDXH: $70.68M vs. MYO: $93.15M
MDXH [@Medical Specialties] is valued at $70.68M. MYO’s [@Medical Specialties] market capitalization is $93.15M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDXH’s FA Score shows that 0 FA rating(s) are green whileMYO’s FA Score has 0 green FA rating(s).

  • MDXH’s FA Score: 0 green, 5 red.
  • MYO’s FA Score: 0 green, 5 red.
According to our system of comparison, MYO is a better buy in the long-term than MDXH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDXH’s TA Score shows that 3 TA indicator(s) are bullish while MYO’s TA Score has 5 bullish TA indicator(s).

  • MDXH’s TA Score: 3 bullish, 5 bearish.
  • MYO’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, MYO is a better buy in the short-term than MDXH.

Price Growth

MDXH (@Medical Specialties) experienced а +8.13% price change this week, while MYO (@Medical Specialties) price change was +11.67% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.80%. For the same industry, the average monthly price growth was -6.16%, and the average quarterly price growth was -2.09%.

Reported Earning Dates

MDXH is expected to report earnings on Aug 14, 2025.

MYO is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Medical Specialties (+4.80% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MYO($93.2M) has a higher market cap than MDXH($70.7M). MYO YTD gains are higher at: -24.224 vs. MDXH (-27.004). MYO has higher annual earnings (EBITDA): -7.71M vs. MDXH (-26.16M). MDXH has more cash in the bank: 32.7M vs. MYO (8.87M). MYO has less debt than MDXH: MYO (601K) vs MDXH (40.7M). MDXH has higher revenues than MYO: MDXH (63.7M) vs MYO (19.2M).
MDXHMYOMDXH / MYO
Capitalization70.7M93.2M76%
EBITDA-26.16M-7.71M339%
Gain YTD-27.004-24.224111%
P/E RatioN/AN/A-
Revenue63.7M19.2M332%
Total Cash32.7M8.87M369%
Total Debt40.7M601K6,772%
FUNDAMENTALS RATINGS
MDXH vs MYO: Fundamental Ratings
MDXH
MYO
OUTLOOK RATING
1..100
1916
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
45
Fair valued
PROFIT vs RISK RATING
1..100
10092
SMR RATING
1..100
9894
PRICE GROWTH RATING
1..100
7659
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
24n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MDXH's Valuation (44) in the null industry is in the same range as MYO (45) in the Medical Distributors industry. This means that MDXH’s stock grew similarly to MYO’s over the last 12 months.

MYO's Profit vs Risk Rating (92) in the Medical Distributors industry is in the same range as MDXH (100) in the null industry. This means that MYO’s stock grew similarly to MDXH’s over the last 12 months.

MYO's SMR Rating (94) in the Medical Distributors industry is in the same range as MDXH (98) in the null industry. This means that MYO’s stock grew similarly to MDXH’s over the last 12 months.

MYO's Price Growth Rating (59) in the Medical Distributors industry is in the same range as MDXH (76) in the null industry. This means that MYO’s stock grew similarly to MDXH’s over the last 12 months.

MYO's P/E Growth Rating (100) in the Medical Distributors industry is in the same range as MDXH (100) in the null industry. This means that MYO’s stock grew similarly to MDXH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MDXHMYO
RSI
ODDS (%)
Bearish Trend 2 days ago
58%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
36%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
31%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 14 days ago
73%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 16 days ago
89%
Bearish Trend 18 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
69%
Aroon
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
MDXH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MYO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPCPY17.330.38
+2.24%
KASIKORNBANK Public Co. Ltd.
DBSDY129.930.37
+0.29%
DBS Group Holdings Ltd.
FMCC5.280.01
+0.19%
Freddie Mac
VEXTF0.09-0.01
-7.70%
Vext Science Inc.
NOKBF4.84-0.46
-8.64%
Nokia Corp.

MDXH and

Correlation & Price change

A.I.dvisor tells us that MDXH and MEHCQ have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MDXH and MEHCQ's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDXH
1D Price
Change %
MDXH100%
+0.58%
MEHCQ - MDXH
28%
Poorly correlated
+7.69%
MYO - MDXH
28%
Poorly correlated
+4.95%
BNGO - MDXH
28%
Poorly correlated
+3.66%
DCTH - MDXH
27%
Poorly correlated
+0.84%
IRIX - MDXH
27%
Poorly correlated
-4.92%
More

MYO and

Correlation & Price change

A.I.dvisor tells us that MYO and NEO have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MYO and NEO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYO
1D Price
Change %
MYO100%
+4.95%
NEO - MYO
32%
Poorly correlated
+1.82%
MXCT - MYO
31%
Poorly correlated
+1.07%
CLPT - MYO
30%
Poorly correlated
+7.85%
BLFS - MYO
28%
Poorly correlated
+1.85%
CERS - MYO
28%
Poorly correlated
-0.73%
More